263 related articles for article (PubMed ID: 27124358)
1. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
Bernardo BC; Yildiz GS; Kiriazis H; Harmawan CA; Tai CMK; Ritchie RH; McMullen JR
Cells; 2022 Oct; 11(19):. PubMed ID: 36231079
[TBL] [Abstract][Full Text] [Related]
5. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
Recamonde-Mendoza M; Werhli AV; Biolo A
Gene; 2019 May; 698():157-169. PubMed ID: 30844478
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
8. AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
Hinkel R; Batkai S; Bähr A; Bozoglu T; Straub S; Borchert T; Viereck J; Howe A; Hornaschewitz N; Oberberger L; Jurisch V; Kozlik-Feldmann R; Freudenthal F; Ziegler T; Weber C; Sperandio M; Engelhardt S; Laugwitz KL; Moretti A; Klymiuk N; Thum T; Kupatt C
J Am Coll Cardiol; 2021 Jun; 77(23):2923-2935. PubMed ID: 34112319
[TBL] [Abstract][Full Text] [Related]
9. AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury.
Hinkel R; Ramanujam D; Kaczmarek V; Howe A; Klett K; Beck C; Dueck A; Thum T; Laugwitz KL; Maegdefessel L; Weber C; Kupatt C; Engelhardt S
J Am Coll Cardiol; 2020 Apr; 75(15):1788-1800. PubMed ID: 32299591
[TBL] [Abstract][Full Text] [Related]
10. Integrated transcriptomic and regulatory network analyses identify microRNA-200c as a novel repressor of human pluripotent stem cell-derived cardiomyocyte differentiation and maturation.
Poon EN; Hao B; Guan D; Jun Li M; Lu J; Yang Y; Wu B; Wu SC; Webb SE; Liang Y; Miller AL; Yao X; Wang J; Yan B; Boheler KR
Cardiovasc Res; 2018 May; 114(6):894-906. PubMed ID: 29373717
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.
Ooi JY; Bernardo BC; McMullen JR
Future Med Chem; 2014 Feb; 6(2):205-22. PubMed ID: 24467244
[TBL] [Abstract][Full Text] [Related]
14. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
Bernardo BC; Gao XM; Tham YK; Kiriazis H; Winbanks CE; Ooi JY; Boey EJ; Obad S; Kauppinen S; Gregorevic P; Du XJ; Lin RC; McMullen JR
PLoS One; 2014; 9(2):e90337. PubMed ID: 24587330
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101.
Xiao L; Gu Y; Sun Y; Chen J; Wang X; Zhang Y; Gao L; Li L
J Cell Physiol; 2019 Aug; 234(8):13680-13692. PubMed ID: 30605239
[TBL] [Abstract][Full Text] [Related]
17. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
[TBL] [Abstract][Full Text] [Related]
18. miR-222 inhibits pathological cardiac hypertrophy and heart failure.
Liu X; Li H; Hastings MH; Xiao C; Damilano F; Platt C; Lerchenmüller C; Zhu H; Wei XP; Yeri A; Most P; Rosenzweig A
Cardiovasc Res; 2024 Mar; 120(3):262-272. PubMed ID: 38084908
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
